It is currently Thu Apr 17, 2014 6:04 pm

News News of Aubagio (teriflunomide)

Site map of Aubagio (teriflunomide) » Forum : Aubagio (teriflunomide)

Aubagio is an oral treatment approved for MS.

aubagio with dinner

I am starting aubagio in a week or so if I get approved by the insurance company. I have been taking rebif for 5 years and always did the rebif around midnight. Since aubagio is suppose to be taken with a meal I wanted to take it with my dinner which is my biggest meal of the day and hopefully I would sleep through side effects like I did with the rebif. Is this a ...
Read more : aubagio with dinner | Views : 1550 | Replies : 5


Aubagio does not appear to affect immune response to flu vac

Aubagio does not appear to affect immune response to flu vaccination in MS patients

Teriflunomide effect on immune response to influenza vaccine in patients with multiple sclerosis.

Abstract

OBJECTIVE: To investigate the effect of teriflunomide on the efficacy and safety of seasonal influenza vaccine.... Read More - http://www.ms-uk.org/index.cfm/aubagio
Read more : Aubagio does not appear to affect immune response to flu vac | Views : 501 | Replies : 0


CHMP also Recommends NAS Designation for Aubagio®

Genzyme receives positive CHMP opinion for Lemtrada™ (alemtuzumab) in Europe

CHMP also Recommends NAS Designation for Aubagio® (teriflunomide) Following Positive Opinion on Approval in March 2013

Genzyme announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion for approval of Lemtrada™ (alemtuzumab) for the treatment of adult patients with relapsing remitting multiple sclerosis (RRMS) with active disease defined by clinical or imaging ...
Read more : CHMP also Recommends NAS Designation for Aubagio® | Views : 2868 | Replies : 0


Aubagio and Hair Loss side effect

I am on month 5 of aubagio (used to take avonex). Everything was great until my hair started shedding! I am freaking out about it. I called Genzyme and all they could tell me was that for "most" people it eventually grew back. No other data available. It is not coming out in clumbs - just shedding all the time. I have very long hair - but my brush is full every 2 days! Anyone ...
Read more : Aubagio and Hair Loss side effect | Views : 3078 | Replies : 34


Aubagio® delays onset of clinically definite MS, study

Genzyme, a Sanofi company, announced today positive top-line results from the TOPIC trial for Aubagio (teriflunomide). The trial was designed to assess whether early initiation of Aubagio (teriflunomide) in patients who experienced their first neurological symptoms consistent with Clinically Isolated Syndrome (CIS) can prevent or delay conversion to clinically definite multiple sclerosis (CDMS)..... Read More - http://www.ms-uk.org/index.cfm/aubagio
Read more : Aubagio® delays onset of clinically definite MS, study | Views : 746 | Replies : 0


Genzyme blitzes Australian MS market with free oral drug

Genzyme blitzes Australian MS market with free oral drug teriflunomide

Image

Drug company Genzyme has launched an aggressive campaign to get its new multiple sclerosis drug teriflunomide prescribed free of charge to patients, in a controversial patient familiarisation program announced the same day the medicine was licensed in Australia.

Each participating neurologist will be able to sign up 10 patients for the once-daily immune system pill, sold under the brand name Aubagio and intended for ...
Read more : Genzyme blitzes Australian MS market with free oral drug | Views : 1403 | Replies : 0


Australian TGA approves Aubagio for relapsing forms of MS

Image

Genzyme, a Sanofi company, has announced that the Australian Therapeutic Goods Administration (TGA) has approved Aubagio® (teriflunomide) 14 mg as a new once-daily, oral treatment indicated for patients with relapsing forms of multiple sclerosis (MS).

The TGA approval will enable health professionals to prescribe Aubagio 14 mg in Australia, which is now the second country to gain marketing authorization for the treatment, following FDA approval in September.

"We are very pleased with the TGA ...
Read more : Australian TGA approves Aubagio for relapsing forms of MS | Views : 1000 | Replies : 0


Aubagio

Hi. I'm new to the forum, but have been reading posts for a while.

I began taking Aubagio 14mg yesterday. It was a LONG day. Problems: nausea, dizzyness, runny nose, aches like the flu, headache, chills, etc. It seemed the side effects were a lot like Avonex, but not as severe. This morning I feel relatively normal, but will take my second dose in about 30 minutes.

I tried injections with Avonex and Copaxone, but ...
Read more : Aubagio | Views : 11650 | Replies : 44


Aubagio® study confirms significant disability impact

Image

Genzyme, a Sanofi company announced today that key data from the TOWER trial were presented at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS). In the study, once-daily, oral Aubagio® 14 mg significantly reduced the annualized relapse rate and slowed progression of disability in patients with relapsing forms of multiple sclerosis (MS) compared to placebo. In addition, the proportion of patients treated with Aubagio who were relapse-free ...
Read more : Aubagio® study confirms significant disability impact | Views : 1420 | Replies : 0


RE FDA NEWS RELEASE ON NEW DRUG AUBAGIO

http://www.fda.gov/NewsEvents/Newsroom/ ... 319277.htm Please read the nwes release by USFDA on the newdrug aubogio
regards
seeva
Read more : RE FDA NEWS RELEASE ON NEW DRUG AUBAGIO | Views : 2663 | Replies : 0


 

Login  •  Register


Statistics

Total posts 216386 • Total topics 22112 • Total members 13904